共 50 条
- [31] Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinomaONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 286 - 290Chmielewska, AgnieszkaKubiatowski, Tomasz
- [32] Pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with IDH1-mutant advanced solid tumors from a phase 1 study.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Fan, BinMellinghoff, Ingo K.Wen, Patrick Y.Pandya, Shuchi SumantJiang, LiewenLiu, GuowenNimkar, TaraYang, HuaDai, David
- [33] Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyLANCET ONCOLOGY, 2020, 21 (06): : 796 - 807Abou-Alfa, Ghassan K.Macarulla, TeresaJavle, Milind M.Kelley, Robin K.Lubner, Sam J.Adeva, JorgeCleary, James M.Catenacci, Daniel V.Borad, Mitesh J.Bridgewater, JohnHarris, William P.Murphy, Adrian G.Oh, Do-YounWhisenant, JonathanLowery, Maeve A.Goyal, LipikaShroff, Rachna T.El-Khoueiry, Anthony B.Fan, BinWu, BinChamberlain, Christina X.Jiang, LiewenGliser, CameliaPandya, Shuchi S.Valle, Juan W.Zhu, Andrew X.
- [34] Molecular Mechanisms Mediating Relapse Following Ivosidenib Monotherapy in Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid LeukemiaBLOOD, 2019, 134Choe, SungWang, HongfangDiNardo, Courtney D.Stein, Eytan M.De Botton, StephaneFathi, Amir T.Tallman, Martin S.Kantarjian, Hagop M.Stone, Richard M.Quek, LynnKonteatis, ZenonDang, LennyZhang, VickieLiu, HuaAttar, Eyal C.Wu, Bin
- [35] Clinical pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with IDH1-mutant advanced hematologic malignancies from a phase 1 study.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Dai, DavidDinardo, Courtney DentonStein, Eytande Botton, StephaneAttar, Eyal C.Liu, Hua
- [36] Ivosidenib (IVO; AG-120) in IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Updated Results from a Phase 1 StudyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S340 - S340DiNardo, Courtney D.Foran, James M.Watts, Justin M.Stein, Eytan M.De Botton, StephaneFathi, Amir T.Prince, Gabrielle T.Stein, Anthony S.Stone, Richard M.Patel, Prapti A.Tallman, Martin S.Choe, SungWang, HongfangZhang, VickieDai, DavidFan, BinYen, Katherine E.Kapsalis, Stephanie K.Hickman, DeniceAgresta, Samuel V.Liu, HuaWu, BinAttar, Eyal C.Kantarjian, Hagop M.
- [37] Molecular Characterization of Clinical Response and Relapse in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib and AzacitidineBLOOD, 2020, 136Daigle, Scott R.Choe, SungDiNardo, Courtney D.Stein, Anthony S.Stein, Eytan M.Fathi, Amir T.Frankfurt, OlgaSchuh, Andre C.Dohner, HartmutMartinelli, GiovanniPatel, Prapti A.Raffoux, EmmanuelTan, PeterZeidan, Amer M.De Botton, StephaneStone, Richard M.Frattini, MarkFranovic, AleksandraXu, EmilyWinkler, ThomasWu, BinVyas, Paresh
- [38] FIBROBLASTS AS PARACRINE TARGETS OF THE ONCOMETABOLITE D-2-HG IN THE IDH1-MUTANT CHOLANGIOCARCINOMA TUMOR MICROENVIRONMENTJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A991 - A992Zabransky, DanielJain, PrernaMody, KabirEl-Refai, SherifJaffee, ElizabethYarchoan, Mark
- [39] Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinomaHEPATOLOGY, 2024,Zabransky, Daniel J.Kartalia, EmmaLee, Jae W.Leatherman, James M.Charmsaz, SorenYoung, Sara E.Chhabra, YashFranch-Exposito, SebastiaKang, MartinMaru, SaumyaRastkari, NoushinDavis, MichaelDalton, William BrianOshima, KiyokoBaretti, MarinaAzad, Nilofer S.Jaffee, Elizabeth M.Yarchoan, Mark
- [40] Clinical and Molecular Profile of IDH1-Mutant Cutaneous MelanomaJOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1122 - 1122Ross, J. S.Elvin, J. A.Sokol, E. S.Shah, N.Miller, V. A.Tse, J. Y.Williams, E. A.